Published: June 14, 2020 | Updated: October 1, 2026
Key Takeaways
- 01. Treatment offered in India:
The centre provides mesenchymal and hematopoietic stem cell therapies in Delhi for patients with Parkinson’s disease. - 02. Intended benefit:
The therapy aims to reduce inflammation, regenerate dopaminergic neurons, and improve motor symptoms such as tremor, rigidity, and gait. - 03. Evidence status:
The article notes that the therapy remains experimental, outcomes vary, and no major regulatory body (such as the FDA) has approved it yet. - 04. Patient factors and context:
Results depend on disease stage, stem cell type, delivery method, and overall health. Continuing standard medical therapies and diagnostics is advised alongside any stem cell treatment.
Parkinson’s Disease — Overview
Parkinson’s disease is a progressive neurodegenerative disorder that often affects movement — caused by loss of dopamine-producing neurons in the substantia nigra, a brain region controlling motor control. As neurons decline, patients develop tremor, stiffness, slowness of movement, and balance problems that impair daily activities and independence.
Current therapies can manage symptoms and improve quality of life but cannot reverse neuronal loss. Stem cell therapy offers regenerative potential by replacing damaged dopaminergic neurons and supporting neural circuits to improve motor function.
At Viezec, our regenerative medicine protocols aim to protect, repair, and rejuvenate neural tissues using safe and ethical stem cell applications — focused on long-term motor preservation and neurological recovery.
Viezec works alongside accredited stem cell hospitals in India to deliver regenerative medicine and stem cell treatment for Parkinson’s disease, targeting the progressive loss of dopamine-producing neurons that causes tremors, muscle rigidity, slowed movement, and balance difficulties. As a dedicated stem cell clinic, our clinical team evaluates each patient individually, using diagnostic assessment to determine whether stem cell therapy is medically appropriate for their specific stage and severity of Parkinson’s.
With over a decade of experience as a trusted stem cell center, Viezec prioritizes evidence-based treatment planning over blanket promises of a cure. Patients frequently consult our stem cell provider network to understand both the clinical rationale for Parkinson’s treatment and the associated treatment cost, and we provide detailed breakdowns for both.
Every case is reviewed by a qualified doctor experienced in stem cell therapy prior to any commitment, ensuring each treatment plan is grounded in clinical judgment rather than generic protocols.
Causes of Parkinson’s Disease Explained
Parkinson’s disease results from progressive loss of dopamine-producing neurons in the brain, caused by a mix of genetic, environmental, and cellular processes that impair movement control and other neurological functions. Early identification of contributing factors supports symptom management and potential regenerative strategies.
- Age-related neuronal vulnerability: Natural aging increases susceptibility of dopaminergic neurons, gradually raising Parkinson’s risk and worsening progression.
- Genetic mutations: Inherited gene changes and family history raise susceptibility to certain Parkinsonian syndromes.
- Environmental toxins: Pesticides, herbicides and chemicals can contribute to neuronal damage.
- Mitochondrial dysfunction and oxidative stress: Cellular energy failure and free radicals damage neurons, steadily accelerating neurodegeneration in susceptible individuals.
- Inflammation and immune responses: Chronic neuroinflammation, driven by microglial activation and systemic immune factors, promotes neuronal loss and disease propagation.
- Lifestyle and vascular factors: Head injury, poor cardiovascular health, and certain exposures influence disease onset and severity.
Early recognition and management of modifiable risks, alongside targeted regenerative approaches, may preserve function and slow progression. At Viezec, our regenerative medicine specialists personalize care based on each patient’s underlying mechanisms.
Symptoms of Parkinson’s Disease
Parkinson’s disease develops gradually, and early symptoms may be subtle or easily overlooked. Recognizing these signs at an early stage helps in managing the condition effectively and maintaining quality of life. Below are some of the most common symptoms noticed among individuals with Parkinson’s disease:
- ✅ Tremors or shaking, especially in hands or fingers
- ✅ Muscle stiffness or rigidity affecting movement
- ✅ Slowed movements (bradykinesia) making tasks take longer
- ✅ Impaired posture or balance issues
- ✅ Changes in speech, facial expressions, or handwriting
⚠️ Important: Consult a neurologist promptly if you notice persistent tremors, slowed movement, or stiffness. Early diagnosis and therapy can help slow disease progression and improve day-to-day function.
Diagnosis of Parkinson’s Disease
Accurate diagnosis of Parkinson’s Disease (PD) is crucial for early detection and optimal management. At Viezec, our specialists use comprehensive neurological assessment and advanced imaging to evaluate motor and non-motor signs, including gait, balance, sleep, and mood, and determine disease stage. Early differentiation from other movement disorders is essential for care.
Standard Diagnostic Tests Include:
- Neurological Examination: Detailed assessment of motor symptoms such as tremor, rigidity, bradykinesia, and postural instability.
- Magnetic Resonance Imaging (MRI): Imaging to rule out structural causes and assess brain changes.
- Dopamine Transporter (DaT) Scan: Functional imaging to evaluate dopamine system integrity and support diagnosis.
- Unified Parkinson’s Disease Rating Scale (UPDRS) and Levodopa Challenge: Quantifies symptoms, functional impact, and response to therapy.
🩺 Clinical Credibility: All PD diagnostic assessments at Viezec are conducted under the supervision of neurologists and movement disorder specialists following international guidelines. This ensures accurate staging, safety, and effective planning before any regenerative therapy or treatment is initiated.
Stem Cell Treatment for Parkinson’s Disease
How It Works
Stem cell therapy for Parkinson’s disease targets the progressive loss of dopaminergic neurons in the substantia nigra that underlies the characteristic motor symptoms. Transplantation of dopaminergic progenitors derived from pluripotent stem cells (iPSCs/ESCs) or mobilized mesenchymal stem cells aims to replace or support the failing neuronal network, supply neurotrophic factors, and reduce local inflammation. These cells can integrate, secrete protective molecules, and enhance synaptic function, which together may improve dopaminergic signaling, reduce neuronal stress, and restore circuitry that controls movement. The combined cell-replacement and paracrine effects contribute to slowing symptom progression and creating conditions that may enable measurable functional improvements in selected patients.
Procedure at Viezec
At Viezec, Parkinson’s treatments follow a multidisciplinary protocol developed by neurologists and regenerative medicine experts. Each step—from detailed neurological evaluation to long-term rehabilitation—is performed in GMP-certified facilities with strict quality controls to ensure cell safety, potency, and traceability throughout the therapy pathway.
- Comprehensive motor and cognitive assessments to determine eligibility
- Selection and preparation of autologous or allogeneic stem cell source
- Cell differentiation into dopaminergic progenitors and GMP processing
- Delivery via stereotactic intracerebral transplant, intrathecal, or intravenous route tailored to the clinical plan
- Post-procedure monitoring, physical therapy, and scheduled follow-ups
Expected Outcomes
Many patients experience stabilization of motor symptoms and modest improvements in tremor, rigidity, bradykinesia, or gait within 3–6 months after treatment. While stem cell therapies are not a guaranteed cure—particularly in advanced or long-standing disease—clinical experience suggests that regenerative approaches can slow symptomatic decline, reduce medication burden in some cases, and improve daily functioning and quality of life for a proportion of treated individuals.
Disclaimer: Outcomes depend on disease stage, patient age, overall neurological health, and prior treatments. Interventions at Viezec are performed under strict medical oversight and are intended to complement established neurologic care, not replace it.
Learn more about Viezec’s stem cell treatment programs for a wide range of neurological disorders and orthopedic conditions.
Stem Cell Delivery Methods for Parkinson’s Disease
How stem cells are delivered affects how many cells reach the brain, how invasive the procedure is, and what risks are involved. Researchers are still studying which route works best for Parkinson’s disease, and no delivery method has been proven to be superior. The routes below are those described in published research and clinical trials.
1. Intravenous (IV) infusion
Cells are given through a vein in the arm, similar to a standard drip.
- How it works: Mesenchymal stem cells (MSCs) are thought to act mainly by releasing growth factors and anti-inflammatory signals, not by becoming new neurons.
- Advantages: Minimally invasive, done as a day-care procedure, with no surgery or anesthesia.
- Limitations: Many infused cells are trapped in the lungs and only a small fraction may reach the brain. Evidence for benefit in Parkinson’s is still limited.
- Possible side effects: Temporary fever, headache, fatigue, or a reaction at the infusion site.
2. Intrathecal injection (lumbar puncture)
Cells are injected into the cerebrospinal fluid (CSF) in the lower back, so they can circulate around the brain and spinal cord.
- Advantages: Bypasses the bloodstream and avoids brain surgery.
- Limitations: Cell distribution is hard to control, and evidence in Parkinson’s is mostly from small, early-stage studies.
- Possible side effects: Headache after the puncture, back pain, infection, and (rarely) nerve irritation.
3. Stereotactic intracerebral transplantation
A neurosurgeon uses MRI-guided navigation to place cells directly into the putamen or other target regions of the brain.
- How it works: This approach is used in clinical trials of dopamine-producing progenitor cells derived from pluripotent stem cells, such as the Kyoto and hES-cell studies listed in our references. It aims to replace lost dopamine neurons, not just support existing ones.
- Advantages: Delivers cells exactly where dopamine is depleted.
- Limitations: It is neurosurgery, performed in specialized centers, usually within regulated trials, and often requires immunosuppression for donor-derived cells.
- Possible risks: Bleeding, infection, seizures, immune rejection, abnormal movements (dyskinesias), and the need for long-term follow-up.
4. Intranasal delivery (experimental)
Cells or cell-derived products are delivered through the nasal passage. This route is still mainly in laboratory and early research, and we do not describe it as an established option.
How the delivery route is chosen
A neurologist selects or advises against a route based on:
- Disease stage and symptom pattern
- Age, overall health, and surgical or anesthesia risk
- Current medications, including blood thinners
- Brain imaging results (MRI)
- Whether a regulated clinical trial is available
What every patient should know before treatment
- Delivery route does not change the fact that stem cell therapy for Parkinson’s is investigational outside approved clinical research.
- It is not a cure and does not replace levodopa or other medications. Never stop or change your medicines without your neurologist.
- Ask for the cell source, how the cells were processed and tested, the exact route, the full risk list, and the follow-up plan, in writing, before agreeing to anything.
- You can also ask whether a registered trial (for example on ClinicalTrials.gov or the CTRI registry in India) is a better option.
Frequently Asked Questions
Can stem cell therapy cure Parkinson’s disease?
No. Stem cell therapy is not currently considered a cure for Parkinson’s disease. Researchers are investigating whether stem cells can help replace or support damaged dopamine-producing neurons, reduce inflammation, and improve neurological function. Some patients report improvements in movement, balance, tremors, and quality of life, but results vary from person to person. Stem cell therapy should be viewed as a potential supportive treatment rather than a guaranteed cure.
How does stem cell therapy work for Parkinson’s disease?
Stem cell therapy aims to support the repair of damaged nervous system tissues. Certain stem cells may release growth factors, reduce inflammation, and help create an environment that supports neuron survival. Researchers are also studying whether stem cells can develop into dopamine-producing cells that may help address some symptoms associated with Parkinson’s disease.
Who is a good candidate for Parkinson’s stem cell therapy?
Candidates are typically individuals diagnosed with Parkinson’s disease who continue to experience symptoms despite standard treatments. Eligibility depends on age, disease progression, medical history, current medications, and overall health. A comprehensive neurological evaluation is usually required before determining whether stem cell therapy may be appropriate.
What improvements do Parkinson’s patients report after stem cell therapy?
Reported improvements may include reduced tremors, better balance, improved walking ability, enhanced muscle control, reduced stiffness, and improvements in daily activities. However, outcomes vary widely, and some patients experience greater benefits than others. No clinic can accurately guarantee specific results.
Is stem cell treatment for Parkinson’s disease safe?
When performed by qualified medical professionals using established safety protocols, stem cell therapy is generally considered relatively safe. However, all medical procedures carry risks. Possible side effects may include temporary discomfort, infection, inflammation, or lack of therapeutic benefit. Patients should discuss risks and benefits with their medical team before treatment.
What type of stem cells are used for Parkinson’s disease treatment?
Different research programs and clinics may use different stem cell types. Commonly discussed options include mesenchymal stem cells (MSCs), neural stem cells, induced pluripotent stem cells (iPSCs), and other regenerative cell therapies. The choice depends on treatment goals, clinical protocols, and physician recommendations.
How long does it take to see results after stem cell therapy for Parkinson’s disease?
Some patients report noticing changes within weeks, while others may require several months before experiencing any improvements. Neurological recovery and tissue repair are gradual processes, and response times vary depending on disease severity, age, rehabilitation efforts, and overall health.
How many stem cell therapy sessions are needed for Parkinson’s disease?
The number of sessions varies depending on the patient’s condition, treatment protocol, and physician recommendations. Some treatment plans involve a single administration, while others may include multiple sessions combined with rehabilitation and follow-up evaluations.
Is stem cell therapy for Parkinson’s disease approved in India?
In India, stem cell therapy is approved for certain specific medical uses, such as some blood-related disorders. For many neurological conditions, including Parkinson’s disease, stem cell therapy is generally considered experimental and may be offered within specific clinical or regulated treatment frameworks. Patients should verify regulatory compliance and treatment details before proceeding.
What is the success rate of stem cell therapy for Parkinson’s disease?
There is currently no universally accepted success rate for stem cell therapy in Parkinson’s disease. Clinical studies have shown promising results for some patients, particularly regarding symptom improvement and quality of life. However, outcomes differ significantly among individuals, and additional research is still underway.
Can stem cell therapy replace Parkinson’s medications?
In most cases, stem cell therapy is not intended to replace prescribed Parkinson’s medications. Many patients continue using medications while receiving supportive regenerative therapies. Any medication changes should only be made under the supervision of a neurologist.
What tests are required before Parkinson’s stem cell treatment?
Patients commonly undergo neurological assessments, medical history reviews, laboratory testing, imaging studies such as MRI scans, medication evaluations, and physical examinations. These assessments help determine eligibility and establish treatment goals.
Can international patients travel to India for Parkinson’s stem cell therapy?
Yes. Many international patients travel to India for stem cell therapy because of the country’s medical infrastructure, specialist expertise, and comparatively lower treatment costs. Treatment providers often assist with consultations, medical coordination, accommodation guidance, and follow-up planning.
What are the risks of stem cell therapy for Parkinson’s disease?
Potential risks may include infection, inflammation, immune reactions, procedural complications, or failure to achieve the desired outcome. Long-term effects continue to be studied, which is why patients should seek treatment from experienced providers that follow established safety standards.
How do I choose a stem cell clinic for Parkinson’s disease?
When considering regenerative medicine for Parkinson’s disease, it’s important to review the clinic’s medical expertise, treatment protocols, and patient support services. Learn how to choose a stem cell clinic for Parkinson’s treatment before making your decision.
For additional information about Parkinson’s disease stem cell therapy, treatment eligibility, safety considerations, and international patient services, please contact our regenerative medicine team for a personalized consultation.
How Much Does Stem Cell Therapy Cost for Parkinson’s Disease?
The cost of stem cell therapy for Parkinson’s disease varies depending on the patient’s stage of Parkinsonism, the type of stem cells used (such as MSCs or neural stem cells), number of treatment sessions, and the expertise of the medical center. Costs also differ globally due to variations in healthcare systems, infrastructure, and regulatory standards. Below is a country-wise comparison to understand how the expenses typically range.
Cost Comparison: Select Countries
The table below represents approximate cost ranges reported by clinics and international patients for a comprehensive stem cell therapy program, including medical evaluation, lab processing, cell transplantation, and post-therapy care.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $22,000 – $38,000 | ₹18,20,000 – ₹31,40,000 |
| United Kingdom 🇬🇧 | $17,000 – $27,000 | ₹14,00,000 – ₹22,30,000 |
| Germany 🇩🇪 | $20,000 – $30,000 | ₹16,50,000 – ₹24,80,000 |
| Singapore 🇸🇬 | $14,000 – $23,000 | ₹11,50,000 – ₹19,00,000 |
While developed countries such as the USA, UK, and Germany offer advanced medical setups, the overall treatment expenses are significantly higher due to costly hospital operations and medical labor. In contrast, India has emerged as a leading destination for affordable and effective stem cell therapy for Parkinson’s disease, offering comparable standards of medical excellence at a fraction of the cost.
India’s lower treatment cost is attributed to reduced operational costs, favorable exchange rates, and efficient healthcare delivery models — without compromising on quality or outcomes. Reputed Indian hospitals employ internationally trained doctors, GMP-certified laboratories, and globally approved treatment protocols to ensure optimal safety and results for Parkinson’s patients.
Why Choose Viezec?
Viezec partners with leading regenerative medicine centers that specialize in neurological disorders like Parkinson’s disease. We ensure that every patient receives ethical, transparent, and world-class medical care — from consultation to follow-up rehabilitation — all aligned with global healthcare standards.
Get a Personalized Cost Estimate
Each Parkinson’s case is unique. Contact our medical team to get a personalized quotation and a customized treatment roadmap based on your specific health profile and progression stage.
Improvements & Results
Based on patient follow-ups at Viezec, many individuals treated for Parkinson’s disease (PD) have reported measurable gains in motor control, daily functioning, and quality of life. Our multidisciplinary team tracks functional outcomes through scheduled neurological assessments to ensure improvements are safe and sustained.
Improved Motor Function
A majority of patients reported gradual reductions in tremor severity and smoother limb movements within 3–6 months after therapy, enabling easier performance of routine tasks. Learn more about PD outcomes.
Better Mobility & Balance
Patients commonly report improved gait stability and confidence when walking, with fewer episodes of freezing and improved ability to navigate daily environments.
Stabilized Progression
Ongoing monitoring demonstrates that many patients show slowed functional decline and sustained improvements on follow-up neurological scales and functional tests.
Patient Experiences
“Within a few months my hand tremors reduced — I can tie my shoes and write legibly again. Daily tasks feel much more manageable and stable.”
– Patient from Mumbai, India
“The therapy helped my walking and confidence — I feel steadier on my feet and less anxious about going out alone.”
– Patient from Abu Dhabi
Mechanism of Action: How Stem Cells Aid Neural Repair in Parkinson’s Disease
Stem cell therapy for Parkinson’s Disease (PD) focuses on replenishing lost dopaminergic neurons and improving motor control. Rather than only replacing damaged nerve cells, stem cells act as biological modulators—secreting neurotrophic factors, anti-inflammatory agents, and antioxidants that foster a healthier neural environment. This regenerative mechanism helps slow neuronal loss and supports functional recovery over time.
- Neuronal Regeneration: Stem cells can differentiate into dopaminergic-like neurons that restore dopamine balance in the brain.
- Neuroinflammation Control: They help regulate inflammatory responses that accelerate neuronal degeneration in the substantia nigra.
- Neuroprotective Support: Stem cells secrete growth and survival factors that protect existing neurons and enhance synaptic function.
- Oxidative Stress Reduction: By releasing antioxidants and protective molecules, stem cells mitigate oxidative injury to brain tissues.
This comprehensive biological action underscores the potential of mesenchymal stem cells (MSCs) in addressing both motor and non-motor symptoms of Parkinson’s Disease. At Viezec, each therapy is conducted under strict clinical oversight to maintain safety, therapeutic precision, and ethical compliance throughout the treatment journey.
Parkinson’s Disease
At Viezec, our regenerative treatment programs for Parkinson’s Disease aim to support and rejuvenate damaged neural pathways through scientifically designed stem cell therapies and personalized neurological care plans. Our goal is to help improve motor function, enhance brain health, and slow disease progression with the highest degree of precision and compassion.
We focus on realistic outcomes supported by clinical research and technological innovation — not exaggerated claims. Our skilled neurology specialists, accredited partner hospitals, and structured follow-up care ensure that every patient receives treatment aligned with global safety and ethical standards.
Treatment Results
Patients who undergo stem cell therapy for Parkinson’s Disease at Viezec frequently report measurable improvements such as reduced tremor intensity, improved bradykinesia (slowness of movement), better postural stability, and easier performance of everyday tasks. The extent of benefit depends on disease stage, degree of neuronal loss, and each patient’s general health.
Careful follow-ups using standardized neurological scales (for example, UPDRS), motor assessments, and imaging studies enable precise tracking of clinical changes and help guide individualized rehabilitation. Recovery timelines differ, but many patients perceive functional gains and improved quality of life within 6–12 months after treatment.
At Viezec, we strive to provide advanced regenerative options; however, we do not promise specific outcomes or a cure. Stem cell therapy effects vary with individual biology and disease characteristics. Since each patient responds differently, it is important to recognise that stem cell therapy for Parkinson’s disease remains research-focused with variable results and no guaranteed success.
Testimonials
Individual experiences shared by patients and families. These reflect personal impressions of their care journey and are not indicative of typical or guaranteed clinical outcomes.
Richard H. – New York, USA – January 2020 – ⭐⭐⭐⭐☆
“Parkinson’s had a real impact on our daily life. The Viezec team took time to explain the evaluation process clearly, and I felt genuinely cared for throughout.”
Anil K. – Pune, India – May 2020 – ⭐⭐⭐⭐⭐
“My father’s care team was attentive from the first consultation. Viezec’s staff gave us honest guidance and support through every stage of his treatment.”
Maria L. – Lisbon, Portugal – October 2021 – ⭐⭐⭐⭐☆
“I appreciated how thoroughly my case was assessed before any treatment plan was proposed. The team at Viezec were patient and easy to communicate with.”
Hassan M. – Doha, Qatar – December 2021 – ⭐⭐⭐⭐⭐
“Viezec’s doctors guided us with professionalism at every step. Their coordination and follow-up made a stressful process feel manageable.”
Olivia S. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐☆
“The Viezec team was transparent about what to expect and stayed in close contact throughout my treatment journey. I felt well-supported the whole time.”
Ahmed R. – Cairo, Egypt – July 2022 – ⭐⭐⭐⭐⭐
“From my first inquiry to follow-up care, Viezec’s coordinators were responsive and thorough. I appreciated the clear communication throughout.”
Sophie D. – Paris, France – April 2023 – ⭐⭐⭐⭐☆
“Living with Parkinson’s brought daily challenges. Viezec’s team was compassionate and explained each step of the process without overpromising results.”
George K. – Sydney, Australia – September 2023 – ⭐⭐⭐⭐⭐
“The combination of physiotherapy guidance and Viezec’s ongoing support gave me confidence in the overall care plan.”
Fatima H. – Dubai, UAE – March 2024 – ⭐⭐⭐⭐☆
“My husband’s care team kept us informed at every stage of treatment. Their honesty and attentiveness gave our family real reassurance.”
Carlos M. – Madrid, Spain – June 2025 – ⭐⭐⭐⭐⭐
“Viezec’s team was thorough and transparent about my treatment plan. I felt genuinely supported and optimistic about the process.”
Success Rates and Outcomes: Stem Cell Therapy for Parkinson’s Disease
Is there a success rate?
No. There is no established or universally accepted success rate for stem cell therapy in Parkinson’s disease. The treatment is still investigational, and the studies so far are small, early-phase trials that mostly measure safety first. Be cautious of any clinic that quotes a precise percentage. Results depend on the cell type, how it is delivered, disease stage, and how “improvement” is defined.
What the research shows so far
| Study type | What was tested | What was reported |
|---|---|---|
| Phase 1/2 trial, Kyoto University (Nature, 2025) | iPS-cell-derived dopamine progenitors, transplanted into the brain | Small trial (7 patients). No serious safety problems reported. Of 6 patients assessed for efficacy, 4 showed improved motor scores when off medication. |
| Phase 1 trial, hES-cell-derived dopamine neurons (Nature, 2025) | Dopamine neurons transplanted into the brain | 12 patients. Treatment was generally well tolerated, and brain imaging suggested the cells survived. Larger trials are needed to show clinical benefit. |
| Mesenchymal stem cell (MSC) trials | Cells given intravenously or intrathecally | Mostly small, early studies. Safety looks acceptable, but evidence of meaningful motor benefit is limited. |
These trials involved a few to a dozen patients, and most had no placebo group. Positive early signals do not prove the treatment works. Larger randomized trials are underway.
Why results vary
- Cell type and source: pluripotent-derived dopamine cells and MSCs work differently.
- Delivery route: direct brain transplant, intrathecal and intravenous routes deliver different amounts of cells to the brain.
- Disease stage and age: earlier-stage patients may respond differently from advanced cases.
- Medication changes: improvements in motor scores can be affected by when medicine was last taken.
- Placebo effect: in Parkinson’s trials, a large share of patients improve even on placebo, which is why controlled studies matter.
How outcomes are measured
Researchers usually track:
- MDS-UPDRS scores (motor symptoms, measured on and off medication)
- Brain imaging, such as F-DOPA PET, to see whether dopamine activity changes
- Daily function and quality-of-life questionnaires
- Safety events, including bleeding, infection, immune reactions and dyskinesias
Our approach to results at Viezec
We do not publish success percentages, because we do not have controlled data that would support them. We help patients understand the published evidence, review their reports with a neurologist, and ask providers for their documented results, trial registration and safety record before any decision is made.
Questions to ask any provider about results
- What exactly was measured, and how, and over what time period?
- Are results published in a peer-reviewed journal or registered on ClinicalTrials.gov or CTRI?
- How many patients were treated, and how many did not improve?
- What were the adverse events?
- Is there a placebo or control group?
Stem cell therapy for Parkinson’s disease is not a cure and does not replace levodopa or other medications. Never change your medicines without your neurologist.
Treatment Disclaimer
The content on this page discusses Parkinson’s Disease and possible management approaches solely for informational and educational purposes. It is not intended to substitute for professional medical consultation, diagnosis, or care. Every patient’s symptom pattern, progression, and response to therapy are unique; the general descriptions provided here may not fully apply to your individual case.
Viezec facilitates medically guided services based on current research, neurological standards, and clinical experience, but we cannot guarantee specific functional outcomes. Treatment decisions should always be made with a qualified neurologist or movement-disorders specialist familiar with your diagnostic findings and medical background.
- What this page does: Provides insight into Parkinson’s causes, available management options, and realistic expectations.
- What this page does not do: Offer individualized medical advice or replace an in-person neurological assessment.
- If symptoms suddenly worsen: Seek prompt evaluation from a neurologist or visit emergency services.
For tailored recommendations, please request a professional neurological evaluation. Our medical team performs a comprehensive review before suggesting any management approach.
What to expect in a professional evaluation
- Detailed review of neurological and general medical history along with movement assessment and diagnostic imaging or tests if indicated.
- Discussion of evidence-based Parkinson’s management options, medication strategies, rehabilitative therapies, and potential benefits and risks.
- Comprehensive informed consent and individualized care planning before initiating any intervention.
Scientific References
The following peer-reviewed publications and clinical studies support current research on stem cell therapy for Parkinson’s Disease.
Conclusion
Parkinson’s disease is a progressive condition caused by the loss of dopamine-producing neurons. Medication, deep brain stimulation for suitable patients, physiotherapy and exercise remain the proven ways to manage symptoms.
Stem cell research is promising, with early trials reporting encouraging safety results. However, the studies are small and early-phase, and larger controlled trials are still needed. Stem cell therapy is not a cure and does not replace standard treatment.
If you are considering it, continue your medications, ask for the evidence and risks in writing, and consider registered clinical trials. Viezec provides consultation and patient support, and we do not guarantee outcomes.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
